MannKind Corporation (MNKD) Financials
MNKD Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 732.3 million | 799.5 million |
| March 31, 2026 | 744.4 million | 803.6 million |
| Dec. 31, 2025 | 792.2 million | 843.2 million |
| Sept. 30, 2025 | 494.6 million | 539.2 million |
MNKD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -23.5 million | 10.2 million |
| March 31, 2026 | -7.5 million | 6.5 million |
| Dec. 31, 2025 | -10.0 million | 7.0 million |
| Sept. 30, 2025 | 22.4 million | 4.3 million |
MNKD Net Income
No data available :(
MNKD Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 111.1 million | 319.1 million | 11.8 million |
| March 31, 2026 | 133.9 million | 320.7 million | 103.1 million |
| Dec. 31, 2025 | 171.3 million | 320.4 million | 103.8 million |
| Sept. 30, 2025 | 260.0 million | 73.4 million | 103.6 million |
MNKD Shares Outstanding
MNKD Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 5.1 million | 18.0 million | 58.3 million | - |
| March 31, 2026 | 1.9 million | 17.2 million | 54.1 million | - |
| Dec. 31, 2025 | 2.0 million | 27.6 million | 58.4 million | - |
| Sept. 30, 2025 | 1.1 million | 14.1 million | 29.1 million | 14.7 million |
MNKD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 109.4 million | 29.5 million |
| March 31, 2026 | 90.2 million | 21.8 million |
| Dec. 31, 2025 | 112.0 million | 24.1 million |
| Sept. 30, 2025 | 82.1 million | 20.2 million |
MNKD Revenue by Segment
Graph available only for paid members. Upgrade to see it.
MNKD
Price: $3.19
52 week price:
Earnings Per Share: -0.15 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.9 million
Ebitda: -28.5 millionMarket Capitalization: 1.2 billion